1. Home
  2. WRBY vs DYN Comparison

WRBY vs DYN Comparison

Compare WRBY & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

HOLD

Current Price

$25.13

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$18.07

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRBY
DYN
Founded
2010
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
WRBY
DYN
Price
$25.13
$18.07
Analyst Decision
Buy
Strong Buy
Analyst Count
11
14
Target Price
$27.10
$37.00
AVG Volume (30 Days)
3.0M
1.5M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
105.88
N/A
EPS
0.03
N/A
Revenue
$871,905,000.00
N/A
Revenue This Year
$14.48
N/A
Revenue Next Year
$16.41
N/A
P/E Ratio
$879.00
N/A
Revenue Growth
13.04
N/A
52 Week Low
$14.96
$8.25
52 Week High
$31.00
$25.00

Technical Indicators

Market Signals
Indicator
WRBY
DYN
Relative Strength Index (RSI) 52.03 51.37
Support Level $24.94 $16.47
Resistance Level $27.97 $19.54
Average True Range (ATR) 1.62 1.05
MACD 0.11 0.08
Stochastic Oscillator 58.53 52.79

Price Performance

Historical Comparison
WRBY
DYN

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: